The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Shifman B.M.
Endocrinology Research Centre, Moscow, Russia
Platonova N.M.
Endocrinology Research Centre, Moscow, Russia
Molashenko N.V.
FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva
Troshina E.A.
Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva
Romanova N.Yu.
Endocrinology Research Centre, Moscow, Russia
Kolesnikova G.S.
Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva
Aldosterone- and cortisol-co-secreting adrenal tumors: an uneasy sum of well-known parts (review)
Journal: Problems of Endocrinology. 2019;65(2): 113‑123
DOI: 10.14341/probl10036
Views: 4747
Downloaded: 82
To cite this article:
Shifman BM, Platonova NM, Molashenko NV, Troshina EA, Romanova NYu, Kolesnikova GS. Aldosterone- and cortisol-co-secreting adrenal tumors: an uneasy sum of well-known parts (review). Problems of Endocrinology.
2019;65(2):113‑123. (In Russ.)
https://doi.org/10.14341/probl10036
Primary aldosteronism (PA) is the most common form of secondary arterial hypertension. In patients with PA, more so than in the general population, there is a prevalence of insulin resistance, diabetes mellitus, metabolic syndrome, osteoporosis, and symptoms of depression; these conditions are more likely to manifest a gluco- rather than mineralocorticoid excess. This fact is of particular importance in light of recent studies that have shown that PA is often associated with glucocorticoid excess. Since the first reports of cases of combined secretion of aldosterone and cortisol in 1979, the number of cases of so-called Connshing syndrome has increased. An analysis of data from recent studies suggests that hypercortisolism in PA is closely associated with an increased risk of cardiovascular complications, metabolic disorders and post-surgical adrenal insufficiency. The most important diagnostic problem in adenomas with combined secretion is the risk of false interpretation of the results of adrenal venous sampling (AVS). The indications that suggest aldosterone-and-cortisol-co-producing adenoma are the lack of suppression of cortisol levels following a night test with 1mg of dexamethasone, and an adrenal tumo of over 2.5cm. As an alternative test capable of differentiating this type of tumor, a number of researchers have proposed measuring the level of so-called hybrid steroids in the peripheral plasma and urine. Taking into account the high prevalence and potential risks, ruling out of excess corisol secretion is obligatory in all cases of PA before AVS and when planning surgery.
Keywords:
Authors:
Shifman B.M.
Endocrinology Research Centre, Moscow, Russia
Platonova N.M.
Endocrinology Research Centre, Moscow, Russia
Molashenko N.V.
FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva
Troshina E.A.
Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva
Romanova N.Yu.
Endocrinology Research Centre, Moscow, Russia
Kolesnikova G.S.
Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.